PTC Therapeutics
PTCT
#3037
Rank
C$7.54 B
Marketcap
C$90.41
Share price
-1.04%
Change (1 day)
2.87%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2026 (TTM): -C$87.46 Million

According to PTC Therapeutics 's latest financial reports the company's current earnings are C$1.00 Billion. In 2025 the company made an earning of C$0.99 Billion, an increase over its 2024 earnings that were of -C$0.52 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$87.46 Million-108.81%
2025 C$0.99 B-291.84%
2024 -C$0.52 Billion-47.84%
2023 -C$1 Billion18.49%
2022 -C$0.84 Billion13.34%
2021 -C$0.74 Billion28.64%
2020 -C$0.58 Billion67.94%
2019 -C$0.35 Billion87.28%
2018 -C$0.19 Billion64.95%
2017 -C$0.12 Billion-45.13%
2016 -C$0.21 Billion-16.72%
2015 -C$0.25 Billion72.64%
2014 -C$0.15 Billion90.89%
2013 -C$73.48 Million96.58%
2012 -C$37.38 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
C$22.11 B-23,241.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
C$7.18 B-7,619.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-C$0.23 Billion 139.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-C$0.19 Billion 95.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-C$0.2 Billion 99.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-C$0.98 Billion 920.71%๐Ÿ‡บ๐Ÿ‡ธ USA